<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Institute of Medicine (IOM) recommends the use of survivorship care plans (SCPs) for <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> survivors </plain></SENT>
<SENT sid="1" pm="."><plain>Developing useful SCPs requires understanding what survivors and their providers need and how SCPs can be implemented in practice </plain></SENT>
<SENT sid="2" pm="."><plain>Published studies investigating the perspectives of stakeholders (survivors, primary care providers, and <z:hpo ids='HP_0002664'>oncology</z:hpo> providers) were reviewed regarding the content and use of SCPs </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> National <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Institute (NCI)-designated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> centers were surveyed concerning the extent to which SCPs for survivors of breast and <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> are in use, their concordance with the IOM's recommendation, and details about SCP delivery </plain></SENT>
<SENT sid="4" pm="."><plain>Survivors and primary care providers typically lack the information the IOM suggested should be included in SCPs </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0002664'>Oncology</z:hpo> providers view SCPs favorably but express concerns about the feasibility of their implementation </plain></SENT>
<SENT sid="6" pm="."><plain>Fewer than one-half (43%) of NCI-designated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> centers deliver SCPs to their breast or <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> survivors </plain></SENT>
<SENT sid="7" pm="."><plain>Of those that do, none deliver SCPs that include <z:hpo ids='HP_0000001'>all</z:hpo> components recommended by the IOM </plain></SENT>
<SENT sid="8" pm="."><plain>Survivors' and providers' opinions about the use of SCPs are favorable, but there are barriers to implementation </plain></SENT>
<SENT sid="9" pm="."><plain>SCPs are not widely used in NCI-designated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> centers </plain></SENT>
<SENT sid="10" pm="."><plain>Variation in practice is substantial, and many components recommended by the IOM framework are rarely included </plain></SENT>
<SENT sid="11" pm="."><plain><z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">CA Cancer</z:e> J Clin 2012; Â© 2012 American <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Society </plain></SENT>
</text></document>